Tfos dews ii epidemiology report

F Stapleton, M Alves, VY Bunya, I Jalbert, K Lekhanont… - The ocular …, 2017 - Elsevier
The subcommittee reviewed the prevalence, incidence, risk factors, natural history, morbidity
and questionnaires reported in epidemiological studies of dry eye disease (DED). A meta …

[HTML][HTML] The progression of geographic atrophy secondary to age-related macular degeneration

M Fleckenstein, P Mitchell, KB Freund, SV Sadda… - Ophthalmology, 2018 - Elsevier
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD)
that leads to progressive and irreversible loss of visual function. Geographic atrophy is …

Gene Editing for CEP290-Associated Retinal Degeneration

EA Pierce, TS Aleman, KT Jayasundera… - … England Journal of …, 2024 - Mass Medical Soc
Background CEP290-associated inherited retinal degeneration causes severe early-onset
vision loss due to pathogenic variants in CEP290. EDIT-101 is a clustered regularly …

Cohort profile update: the study of health in Pomerania (SHIP)

H Völzke, J Schössow, CO Schmidt… - International journal …, 2022 - academic.oup.com
The Study of Health in Pomerania (SHIP) comprises the two independent cohorts SHIP-
START (recruited between 1997 and 2001) and SHIP-TREND (recruited between 2008 to …

Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy

P Yu-Wai-Man, NJ Newman, V Carelli… - Science translational …, 2020 - science.org
REVERSE is a randomized, double-masked, sham-controlled, multicenter, phase 3 clinical
trial that evaluated the efficacy of a single intravitreal injection of rAAV2/2-ND4 in subjects …

Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial

A Azuara-Blanco, J Burr, C Ramsay, D Cooper… - The Lancet, 2016 - thelancet.com
Background Primary angle-closure glaucoma is a leading cause of irreversible blindness
worldwide. In early-stage disease, intraocular pressure is raised without visual loss …

Retinitis pigmentosa: current clinical management and emerging therapies

XTA Nguyen, L Moekotte, AS Plomp… - International Journal of …, 2023 - mdpi.com
Retinitis pigmentosa (RP) comprises a group of inherited retinal dystrophies characterized
by the degeneration of rod photoreceptors, followed by the degeneration of cone …

[HTML][HTML] Efficacy and safety of intravitreal gene therapy for Leber hereditary optic neuropathy treated within 6 months of disease onset

NJ Newman, P Yu-Wai-Man, V Carelli, ML Moster… - Ophthalmology, 2021 - Elsevier
Purpose To evaluate the efficacy of a single intravitreal injection of rAAV2/2-ND4 in subjects
with visual loss from Leber hereditary optic neuropathy (LHON). Design RESCUE is a …